The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0% according to a new report by MarketsandMarkets™. The growth of the anatomical pathology market is mainly driven by the high incidence of cancer and other target diseases, cancer screening recommendations, reimbursement possibilities, and growing interest in personalized medicine.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
Browse in-depth TOC on "Anatomic Pathology Market"
491 – Tables
45 – Figures
343 – Pages
Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market.
Based on product service, the anatomic pathology market is segmented into services, consumables, and instruments. The services segment accounted for the largest market share
By Application, disease diagnostics accounted for the largest market share
Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment accounted for a larger share of the market
By End User, Hospital laboratories accounted for the largest market share
Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories accounted for the largest share
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145
North America dominates the anatomic pathology market
The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.
The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).
Browse Adjacent Markets: Medical Devices Market Research Reports Consulting
